Table 10 |
||
|
Biphasic rapid and long-acting insulin analogs |
||
|
Insulin aspart and protaminated (70%) + insulin aspart (30%) |
NovoMix® 70/30 |
Pre-mix with 70% long-acting insulin aspart (up to 24 hours) + 30% aspart insulin of immediate release, short acting (4-6 hours), to control post-prandial and interprandial glycemic levels |
|
Neutral protamine insulin lispro (75%) + insulin lispro (25%) |
Humalog® Mix 25 |
Pre-mix with 75% intermediate acting insulin NPL (up to 24 hours) + 25% insulin of immediate release, short-acting (4-5 hours), to control post-prandial and interprandial glycemic levels |
|
Neutral protamine insulin lispro (50%) + insulin lispro (50%) |
Humalog® Mix 50 |
Pre-mix with 50% intermediate acting insulin NPL (up to 24 hours) + 50% insulin of immediate release, short-acting (4-5 hours), to control post-prandial and interprandial glycemic levels |
|
|
||
|
This table presents only a partial list of commercial medications of various drugs and does not represent a specific recommendation of any commercial brand. |
||
|
Lerario et al. Diabetology & Metabolic Syndrome 2010 2:35 doi:10.1186/1758-5996-2-35 |
||